Paid Clinical Trials in Grand Junction, CO
As of August 2026, 42 paid clinical trials are recruiting in Grand Junction, Colorado. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Grand Junction offers studies at sites including Saint Mary's Hospital and Regional Medical Center for conditions such as Breast Neoplasms, Non-small Cell Lung Cancer, Breast Cancer, Chronic Lymphocytic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Grand Junction
Trials by drug in Grand Junction
Filter results
41 clinical trials
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Improving Care for Rural Patients With Solid Tumors
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Top Research Study Locations in Grand Junction
Researchers run research studies in Grand Junction, CO at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Mary's Hospital and Regional Medical Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 11 |
| Grand Valley Oncology | Chronic Lymphocytic Leukemia, Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma | 6 |
| Cancer Centers of Colorado St. Mary's Regional Hospital | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 4 |
| Intermountain Health St. Mary's Regional Hospital | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 4 |
| Glaukos Investigative Site | Glaucoma, Persistent Corneal Epithelial Defect | 2 |
| VA Western Colorado Health Care System | Bladder Cancer, Breast Cancer, Cervical Cancer | 2 |
| ICON Eye Care | Open Angle Glaucoma (OAG), Cataract | 2 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Colorado West Healthcare System - Grand Valley Oncology | Carcinoma, Transitional Cell, Neoplasm Metastasis, Urinary Bladder Neoplasms | 1 |
| Colorado West Healthcare System dba Grand Valley Oncology | Extensive Stage Small-cell Lung Cancer, Small-cell Lung Cancer | 1 |
| Colorado West Healthcare System-Grand Valley Oncology | Lymphoma, Large B-Cell, Diffuse | 1 |
| Intermountain Health | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0500 | Non-small Cell Lung Cancer | 1 |
| Ohio State University Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
| Redlands Mesa Surgery Center | Lumbar Spinal Stenosis | 1 |
| SCL- St. Mary's Medical Center | Bladder Cancer, Breast Cancer, Cervical Cancer | 1 |
| Saint Mary's Regional Hospital - Cancer Centers of Colorado | Breast Cancer, Metastatic | 1 |
| St. Mary's Hospital and Medical Center | Parkinson's Disease | 1 |
| St. Mary's Regional Hospital | Staphylococcus Aureus Bacteremia | 1 |
| St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado | Breast Neoplasms | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
Active & Upcoming Studies in Grand Junction (2026)
Recruiting trials in Grand Junction grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (28 active studies)
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial · Phase 3 · NRG Oncology
- Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT. · bioAffinity Technologies Inc.
Eye & vision (3 active studies)
- Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma · Avisi Technologies Inc.
- Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant · Phase 2, Phase 3 · Glaukos Corporation
Neurology & pain (1 active study)
Common conditions studied in Grand Junction
- Breast Neoplasms (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Breast Cancer (2 active studies)
- Chronic Lymphocytic Leukemia (2 active studies)
- Neoplasm Metastasis (2 active studies)
- Non-Small Cell Lung Cancer (2 active studies)
Leading research sponsors in Grand Junction
- Merck Sharp & Dohme LLC
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Grand Junction?
There are approximately 42 recruiting clinical trials in Grand Junction, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Grand Junction pay participants?
Most recruiting trials in Grand Junction compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Grand Junction?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Grand Junction?
The most common conditions under active study in Grand Junction include Breast Neoplasms (3), Non-small Cell Lung Cancer (3), Breast Cancer (2), Chronic Lymphocytic Leukemia (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Grand Junction?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Grand Junction on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Grand Junction?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Grand Junction?
Recruiting research sites in Grand Junction include Saint Mary's Hospital and Regional Medical Center, Grand Valley Oncology, Cancer Centers of Colorado St. Mary's Regional Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Grand Junction right now?
The largest active categories in Grand Junction are Cancer & tumors (28), Eye & vision (3), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.